Centers for Disease Control & Prevention (CDC). RSV vaccine guidance for older adults. CDC. https://www.cdc.gov/. 30 Aug 2024. Accessed 17 Jun 2025.
Lee PI, Huang YC, Liu CC, et al. Recommendation for the use of respiratory syncytial virus vaccines. J Microbiol Immunol Infect. 2025 Feb;58(1):1-6. doi: 10.1016/j.jmii.2024.12.010. Accessed 18 Jun 2025. PMID: 39794196
Alfano F, Bigoni T, Caggiano FP, et al. Respiratory syncytial virus infection in older adults: an update. Drugs Aging. 2024 Jun;41(6):487-505. doi: 10.1007/s40266-024-01118-9. Accessed 21 Nov 2024. PMID: 38713299
Australian Government. Australian immunization handbook. Australian Government. https://immunisationhandbook.health.gov.au/. 09 Oct 2024.
Barr F, Graham B. Respiratory syncytial virus infection: clinical features and diagnosis in infants and children. UpToDate. https://www.uptodate.com/. 10 Sep 2024.
Centers for Disease Control and Prevention (CDC). Adult immunization schedule notes. CDC. https://www.cdc.gov/. 06 Dec 2023.
Centers for Disease Control and Prevention (CDC). Clinical overview of RSV. CDC. https://www.cdc.gov/. 30 Aug 2024.
Gatt D, Martin I, Al Fouzan R, et al. Prevention and treatment strategies for respiratory syncytial virus (RSV). Pathogens. 2023 Jan;12(2):154. doi: 10.3390/pathogens12020154. PMID: 36839426
Ison M, Nam H. Respiratory syncytial virus infection in adults. UpToDate. https://www.uptodate.com/. 15 Oct 2024. Accessed 21 Nov 2024.
National Health Service (NHS). Respiratory syncytial virus (RSV). NHS. https://www.nhs.uk/. 05 Jul 2024. Accessed 21 Nov 2024.
American Society for Clinical Pathology (ASCP). FDA approved Clesrovimab to protect against RVS in infants. ASCP. https://www.ascp.org/. 10 Jun 2025.
European Medicines Agency (EMA). mResvia. EMA. https://www.ema.europa.eu/. 09 Jun 2024.
Pfizer. ACIP votes to expand recommendation for Pfizer's RSV vaccine Abrysvo to include adults 50 to 59 at increased risk of disease. Pfizer. https://www.pfizer.com/. 16 Apr 2025.
United States Food and Drug Administration (US FDA). FDA approved first respiratory syncytial virus (RSV) vaccine. US FDA. https://www.fda.gov/. 2023 May 03.
World Health Organization (WHO). WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines. WHO. https//www.who.int/. 01 Jan 2017.
Centers for Disease Control & Prevention (CDC). Respiratory syncytial virus. Vaccines for older adults. CDC. https://www.cdc.gov/. 25 Feb 2025.
Centers for Disease Control & Prevention (CDC). RSV vaccine VIS. CDC. https://www.cdc.gov/. 30 Aug 2024.
Ernst D. ACIP recommends RSV vaccine for 50 to 59-year-olds at high risk. Vaccine Advisor. https://www.vaccineadvisor.com/. 22 Apr 2025.
National Centre for Immunisation Research and Surveillance (NCIRS). Respiratory syncytial virus (RSV): frequently asked questions (FAQs). NCIRS. https://ncirs.org.au/. 2025.
Australian Government. Australian immunisation handbook: respiratory syncytial virus. Australian Government. https://immunisationhandbook.health.gov.au. 17 Jan 2025. Accessed 02 Jul 2025.
